Researchers assessed whether a set dose of luspatercept could be safe in treating pediatric patients with non–transfusion dependent beta-thalassemia.

Doctors treating ICU patients on ventilators face a constant challenge regarding nutrition. Now, an AI system can help.

Social media platforms have spent the past three years fending off congressional efforts that would force platforms to take a firmer hand in mitigating issues related to mental health, addiction and ...

Concise regulatory statusPivotal trialOveporextonTakedaNarcolepsy (orexin‑2 agonist)US, EU, JPPhase III completed; filings ...

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the ...

View post: AT&T follows T-Mobile with bold move to win back customers View post: After Rate Cut, Fed Chair Jerome Powell Credits Automation and AI For Contributing to This "Structural" Boom in the U.S ...

President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of the burden of the costs of medicines. By Rebecca Robbins and Eshe Nelson ...

The Trump administration reached a deal with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National ...

CSL shares are down roughly 40% since acquiring Vifor in August 2022, an iron deficiency and kidney disease business and the largest acquisition in its history. However, several other factors have ...

A judge in Minnesota is facing heat after she overturned a guilty verdict for an individual convicted in a $7.2 million fraud scheme that involved taxpayer money. Abdifatah Yusuf and his wife Lul ...

Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer. The federal Food and Drug ...

Merck & Co., a pharmaceutical company that has been around for 133 years, announced in November 2025 that it will cut 204 jobs at its headquarters in Rahway, New Jersey, by February 2026. These local ...